Navigation Links
Chimerix's Broad Spectrum Antiviral Therapeutic, CMX001, Demonstrates Potential To Mitigate BK Virus Associated End-Organ Disease In Clinical Study
Date:7/23/2012

RESEARCH TRIANGLE PARK, N.C., July 23, 2012 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced the presentation of data showing that its lead antiviral compound, CMX001, has the potential to reduce end-organ damage associated with BK virus (BKV) in hematopoietic stem cell transplant (HSCT) recipients.  This new retrospective analysis, entitled "CMX001, a Novel Broad Spectrum Antiviral, May Mitigate Signs of BK Virus (BKV) Associated Bladder and Kidney End-Organ Damage," was presented at the 24th International Congress of the Transplantation Society in Berlin, Germany.

BKV infection is commonly observed post solid organ transplant (SOT) and is associated with renal dysfunction and potential kidney graft loss.  BKV is also known to cause hemorrhagic cystitis (a painful inflammatory bladder condition) in HSCT recipients, but the incidence and impact of BKV infection on bladder or kidney dysfunction in this patient population have been less well characterized.  Herve Mommeja-Marin, MD, Vice President of Clinical Research at Chimerix, presented the BKV data from the Phase 2 Study CMX001-201, which had as its primary objective the evaluation of CMX001 versus placebo for the prevention of cytomegalovirus (CMV) infection in 230 HSCT recipients.  Phase 2 results presented elsewhere have shown that CMX001, at various doses, was active and well-tolerated in the prevention of CMV infection or disease.   

The observations from Study 201 represent the largest retrospective analysis of BKV-associated signs and symptoms collected in a randomized, placebo-controlled trial reported to date.  In Study 201, which evaluated only HSCT recipients, there was a high incidence of BKV infection: BKV was measurable in the urine samples of 55% (126/230) of subjects at some time during the study period.  Of these subjects, 80% (101/126) were positive
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. The Biomedical Device Industry in America: Challenges at Home and Abroad
2. Polish Medicine Attracts Patients From Abroad - Not Only During EURO 2012
3. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
4. Broad Patent Protection Granted for iBio Immunomodulator
5. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
6. Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth
7. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
8. Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of Pol I as New Approach to Cancer Therapy
9. LIVE VIA SATELLITE: Physician Demonstrates New Medical Technology to Combat Back Pain without Major Surgery
10. Six-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib
11. Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015  Delays in ... projects can slow down the decision-making process, resulting ... therefore, absolutely critical for biopharmaceutical companies to develop ... approval process for quicker and more meaningful insights. ... Best Practices, LLC, nearly three-quarters of benchmarked study ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... announced the addition of the "Investigation Report on ... Developed by Roche under the trade name ... in the world. In Feb.26, 2010, it was approved ... injections available in China all ...
(Date:8/28/2015)... Ill. , Aug. 28, 2015 ... Companies, Inc. (Nasdaq: PDCO ), is now ... previously announced acquisition of Patterson Medical by Madison ... will retain its name for a transition period ... of rehabilitation and sports medicine products.  With the ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Bevacizumab Market 2015-2019 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3
... 2011 Encision Inc. (ECIA:PK), a medical device company ... standard of care in minimally-invasive surgery, announced today that ... of certain electrode tips used in its AEM® surgical ... to breaking off as a consequence of aggressive cleaning ...
... MONTGOMERYVILLE, Pa., Oct. 17, 2011 For the 7.5 ... more than just shorter days, less access to sunlight ... symptoms. With XTRAC® Excimer Laser ( www.XTRACLaser.com ) treatments, psoriasis ... Although every season provides its own unique set of ...
Cached Medicine Technology:Encision Announces Voluntary Recall of Certain Electrode Product 2XTRAC Excimer Laser Provides Relief for Psoriasis Sufferers' Fall Flare-Ups 2XTRAC Excimer Laser Provides Relief for Psoriasis Sufferers' Fall Flare-Ups 3XTRAC Excimer Laser Provides Relief for Psoriasis Sufferers' Fall Flare-Ups 4
(Date:8/31/2015)... Boston, MA (PRWEB) , ... August 31, 2015 , ... ... the Dietary Guidelines advice to "make at least half your grains whole,” with the ... The Boston-based non-profit Oldways Whole Grains Council (WGC) released these findings and ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... efficacy endpoint data collection, cloud analytics and workflow solutions will demonstrate multiple prototypes ... in Lisbon, Portugal, September 22-24, 2015. This is the only European event dedicated ...
(Date:8/31/2015)... ... 31, 2015 , ... On Saturday, July 11, 2015, during the annual New ... City, NYSATA was proud to recognize Dr. Merritt F. Spear as the 2015 recipient ... named after long-time NYSATA member and Ithaca College athletic trainer and educator, is considered ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Intellitec Solutions announced ... by bringing on board their 8th new staff member in 2015. With the potential ... the firm. Intellitec Solutions supports Microsoft Dynamics GP, Dynamics SL, Dynamics CRM and Intacct, ...
(Date:8/31/2015)... ... ... All birth control methods work best if used correctly every time you have ... Moreover, no-scalpel vasectomy has many proven advantages with a lower complication rate over the ... are afraid of complications. , One Stop Medical Center reported a zero failure ...
Breaking Medicine News(10 mins):Health News:Most Americans Now Make Half Their Grains Whole 2Health News:Most Americans Now Make Half Their Grains Whole 3Health News:Most Americans Now Make Half Their Grains Whole 4Health News:Most Americans Now Make Half Their Grains Whole 5Health News:ERT to Demonstrate Innovation Lab Prototypes at European PRO / eCOA Congress 2Health News:ERT to Demonstrate Innovation Lab Prototypes at European PRO / eCOA Congress 3Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 2Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 3Health News:Intellitec Solutions Achieves Record Pace for New Hiring 2Health News:One Stop Medical Center of Twin Cities Achieves Zero Failure Rate and Infection Rate in No Scalpel Vasectomy 2
... in Honor of National Family Caregiver Month, NAPLES, ... Month, AgingCare.com wants to make a deserving caregiver,s life,a ... $2,000 of,free housecleaning., To enter the contest, family ... sweet moment they,ve shared with their,loved one, some upbeat ...
... MONICA, Calif., Nov. 13 Cord Blood,America, Inc. ... stem,cell preservation company ( http://www.cordblood-america.com ) focused on,bringing ... families nationwide and,internationally, said today that a letter ... on the Company,s website. The letter explains,some of ...
... Comedy Writer, Alan Zweibel, Keynote Speaker, NEW ... tickets,for Turn the Corner Foundation,s, http://www.turnthecorner.org, ... The big event, Unmask a,Cure, will be held ... in,New York City. Celebrities and prominent physicians involved ...
... Hospital, a state-run,psychiatric hospital in the Catawba Valley ... comfort systems to make the buildings,more energy efficient ... hospital anticipates $1 million in savings over five ... associated with the new,heating, ventilating and air conditioning ...
... launch Moxatag(TM), the first and only FDA-approved ... of 2009, GERMANTOWN, Md., Nov. 13 , ... closed a $100 million financing transaction with ... -- MiddleBrook repurchased the Keflex(R) assets for approximately $11.0 ...
... Sports and,Nutritional Supplements developer and manufacturer ... that the company,s primary operating,subsidiary, Interactive Nutrition ... exclusive contract for manufacturing and distribution of ... Sigurdur Arnason and,companies owned by Sigurdur Arnason. ...
Cached Medicine News:Health News:People Caring for Aging Parents Can Win $2,000 of Free Housecleaning 2Health News:Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders 2Health News:Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders 3Health News:Turn the Corner Honors Andy Abrahams Wilson, Director of Under Our Skin, for His Dedication in the Fight Against Lyme Disease 2Health News:Turn the Corner Honors Andy Abrahams Wilson, Director of Under Our Skin, for His Dedication in the Fight Against Lyme Disease 3Health News:Virginia Mental Health Hospital Improves Patient Comfort, Receives Award for Energy-Saving Renovations 2Health News:Virginia Mental Health Hospital Improves Patient Comfort, Receives Award for Energy-Saving Renovations 3Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 2Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 3Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 4Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 5Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 6Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 7Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 8Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 9Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 10Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 11Health News:Natural Nutrition Canadian Subsidiary Signs $50.5 Million (CDN) Five Year European Distribution Contract 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: